Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

ASO Webinar: Obesity and Kidney Disease

Thu, 27/01/2022 · 18:00 · London
About This Webinar

Obesity is increasingly becoming a common cause for chronic kidney disease, even in the absence of diabetes or hypertension. In this webinar Dr Neil Docherty, Dr Andrew Frankel and Dr Ricardo Cohen will be discussing the pathophysiology, and medical and surgical treatment options for people with obesity and kidney disease. This will include pharmacotherapy and bariatric surgery to achieve the BMI cut offs for kidney transplantation.

18:00 Opening and introduction - Dr Alex Miras

18:05 Obesity and Chronic Kidney Disease From Association to Causation - Dr Neil Docherty

18:25 Medical treatment of chronic kidney disease associated with obesity with and without diabetes - Dr Andrew Frankel

18:50 Metabolic/Bariatric surgery as a renoprotective intervention - Dr Ricardo Cohen

19:10 Panel Q & A/ discussion

Please join us for the live panel discussion and Q & A session

Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fully fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO. None of the speakers have received a fee for their participation in this webinar, and ASO has been fully responsible for engaging with participants.

Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
I am Associate Professor (Anatomy) at The University College Dublin (UCD) School of Medicine and Principal Investigator at The UCD Diabetes Complications Research Centre at The UCD Conway Institute. I am interested in the role of obesity and diabetes as modifiable risk factors for the development and progression of chronic kidney disease. To this end, I co-lead translational research studies at The UCD Metabolic Medicine group wherein we work to identify and characterise optimised surgical and medical approaches for the treatment of obesity, type 2 diabetes and associated chronic kidney disease.
Webinar hosting presenter
Dr Andrew Frankel consultant physician at Imperial College Healthcare NHS trust Over the years he has maintained a significant research interest in relation to diabetes and the kidney, both in terms of how diabetes affects the kidneys leading to deterioration in kidney function, but also in relation to how the presence of kidney disease influences the management of diabetes.
Webinar hosting presenter
Director
The Center for the treatment of Obesity and Diabetes
Hospital Oswaldo Cruz, Sao Paulo, Brasil
Past President - Brazilian Society for Bariatric and Metabolic Surgery (2011-2012)
Past President -International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), Latin American Chapter (2018-2019)
Webinar hosting presenter
Alex Miras is a Senior Lecturer and Consultant in Endocrinology and Obesity Medicine at Imperial College London. His clinical and research work focus solely on Obesity. He has contributed to the clinical management and research in Obesity over the last 10 years, through his work at a high throughput Obesity Centre. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices and obesity surgery.